Unknown

Dataset Information

0

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.


ABSTRACT: There are nearly 50 million people with Alzheimer's disease (AD) worldwide and currently no disease modifying treatment is available. AD is characterized by deposits of Amyloid-? (A?), neurofibrillary tangles, and neuroinflammation, and several drug discovery programmes studies have focussed on A? as therapeutic target. Active immunization and passive immunization against A? leads to the clearance of deposits in humans and transgenic mice expressing human A? but have failed to improve memory loss. This review will discuss the possible explanations for the lack of efficacy of A? immunotherapy, including the role of a pro-inflammatory response and subsequent vascular side effects, the binding site of therapeutic antibodies and the timing of the treatment. We further discuss how antibodies can be engineered for improved efficacy.

SUBMITTER: Sumner IL 

PROVIDER: S-EPMC5924811 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

Sumner Isabelle L IL   Edwards Ross A RA   Asuni Ayodeji A AA   Teeling Jessica L JL  

Frontiers in neuroscience 20180423


There are nearly 50 million people with Alzheimer's disease (AD) worldwide and currently no disease modifying treatment is available. AD is characterized by deposits of Amyloid-β (Aβ), neurofibrillary tangles, and neuroinflammation, and several drug discovery programmes studies have focussed on Aβ as therapeutic target. Active immunization and passive immunization against Aβ leads to the clearance of deposits in humans and transgenic mice expressing human Aβ but have failed to improve memory los  ...[more]

Similar Datasets

| S-EPMC9456695 | biostudies-literature
| S-EPMC4664306 | biostudies-literature
| S-EPMC4051211 | biostudies-other
| S-EPMC3979042 | biostudies-literature
| S-EPMC3857643 | biostudies-other
| S-EPMC5527287 | biostudies-literature
| S-EPMC9741026 | biostudies-literature
| S-EPMC8572878 | biostudies-literature
| S-EPMC10152635 | biostudies-literature
| PRJNA683625 | ENA